- Home
- ZURA vs DBI Comparison
ZURA vs DBI Comparison
Compare ZURA & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- DBI
- Stock Information
- Founded
- ZURA 2022
- DBI 1991
- Country
- ZURA United States
- DBI United States
- Employees
- ZURA N/A
- DBI N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- DBI Clothing/Shoe/Accessory Stores
- Sector
- ZURA Health Care
- DBI Consumer Discretionary
- Exchange
- ZURA Nasdaq
- DBI Nasdaq
- Market Cap
- ZURA 69.9M
- DBI 136.7M
- IPO Year
- ZURA N/A
- DBI 1991
- Fundamental
- Price
- ZURA $1.30
- DBI $2.82
- Analyst Decision
- ZURA Buy
- DBI Hold
- Analyst Count
- ZURA 7
- DBI 2
- Target Price
- ZURA $14.33
- DBI $3.50
- AVG Volume (30 Days)
- ZURA 689.3K
- DBI 1.7M
- Earning Date
- ZURA 08-08-2025
- DBI 06-10-2025
- Dividend Yield
- ZURA N/A
- DBI 7.12%
- EPS Growth
- ZURA N/A
- DBI N/A
- EPS
- ZURA N/A
- DBI N/A
- Revenue
- ZURA N/A
- DBI $2,949,575,000.00
- Revenue This Year
- ZURA N/A
- DBI N/A
- Revenue Next Year
- ZURA N/A
- DBI $2.45
- P/E Ratio
- ZURA N/A
- DBI N/A
- Revenue Growth
- ZURA N/A
- DBI N/A
- 52 Week Low
- ZURA $0.97
- DBI $2.18
- 52 Week High
- ZURA $5.07
- DBI $8.45
- Technical
- Relative Strength Index (RSI)
- ZURA 58.73
- DBI 56.50
- Support Level
- ZURA $1.00
- DBI $2.37
- Resistance Level
- ZURA $1.45
- DBI $3.20
- Average True Range (ATR)
- ZURA 0.10
- DBI 0.20
- MACD
- ZURA 0.02
- DBI 0.09
- Stochastic Oscillator
- ZURA 66.67
- DBI 86.70
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.